Health

Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

TribeNews
By TribeNews Add a Comment
0 Min Read
Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

MedPage Today) — New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app